Urinary dysfunction in early and untreated Parkinson's disease

被引:80
作者
Uchiyama, Tomoyuki [1 ]
Sakakibara, Ryuji [2 ]
Yamamoto, Tatsuya
Ito, Takashi
Yamaguchi, Chiharu [3 ]
Awa, Yusuke [4 ]
Yanagisawa, Mitsuru [4 ]
Higuchi, Yoshinori [5 ]
Sato, Yasunori [6 ]
Ichikawa, Tomohiko [4 ]
Yamanishi, Tomonori
Hattori, Takamichi
Kuwabara, Satoshi
机构
[1] Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan
[2] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Japan
[3] Chiba Univ Hosp, Cent Lab Unit, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Urol, Chiba 2608670, Japan
[5] Chiba Univ, Grad Sch Med, Dept Neurosurg, Chiba 2608670, Japan
[6] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan
关键词
MULTIPLE SYSTEM ATROPHY; NONMOTOR SYMPTOMS QUESTIONNAIRE; SPHINCTER ELECTROMYOGRAPHY; VOIDING DYSFUNCTION; BLADDER FUNCTION; ANAL-SPHINCTER; PREVALENCE; DIAGNOSIS; STANDARDIZATION; MICTURITION;
D O I
10.1136/jnnp.2011.241075
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Urinary dysfunction is common in Parkinson's disease (PD); however, little is known about urinary dysfunction in early and untreated PD patients. Methods Fifty consecutive untreated PD patients (mean age, 66.7; mean disease duration, 23.6 months; and mean Hoehn & Yahr scale, 1.9) were recruited; those with other conditions that might have influenced urinary function were excluded. Patients were evaluated using a urinary questionnaire and urodynamic studies. Results Sixty-four per cent complained of urinary symptoms (storage, 64.0%; voiding, 28.0%). Urodynamic studies showed abnormal findings in the storage phase in 84%, with detrusor overactivity (DO) and increased bladder sensation without DO in 58.0% and 12.0% of patients, respectively. In the voiding phase, detrusor underactivity, impaired urethral relaxation such as detrusor sphincter dyssynergia, and bladder outlet obstruction were present in 50.0%, 8.0% and 16% of patients, respectively. In patients with both storage and voiding phase abnormalities, DO+detrusor underactivity was the most common finding. Few patients experienced urge incontinence and/or quality-of-life impairment owing to urinary dysfunction; none had low-compliance bladder or abnormal anal-sphincter motor unit potential. These urinary symptoms and urodynamic findings were not correlated with gender, disease severity or motor symptom type. Conclusion Urinary dysfunction, manifested primarily as storage disorders with subclinical voiding disorders and normal anal-sphincter electromyography, occurs in early and untreated PD patients. In cases with severe voiding disorder and/or abnormal anal-sphincter electromyography, other diagnoses should be considered.
引用
收藏
页码:1382 / 1386
页数:5
相关论文
共 39 条
[31]   BIPHASIC EFFECT OF APOMORPHINE, AN ANTI-PARKINSONIAN DRUG, ON BLADDER FUNCTION IN RATS [J].
Uchiyama, T. ;
Sakakibara, R. ;
Yoshiyama, M. ;
Yamamoto, T. ;
Ito, T. ;
Liu, Z. ;
Yamaguchi, C. ;
Awa, Y. ;
Yano, H. -M. ;
Yanagisawa, M. ;
Yamanishi, T. ;
Hattori, T. ;
Kuwabara, S. .
NEUROSCIENCE, 2009, 162 (04) :1333-1338
[32]   Life style risks of Parkinson"s disease: Association between decreased water intake and constipation [J].
Ueki, A ;
Otsuka, M .
JOURNAL OF NEUROLOGY, 2004, 251 (Suppl 7) :18-23
[33]  
Vodusek DB, 1999, NEUROLOGY BLADDER BO
[34]   Prevalence of bladder dysfunction in Parkinsons disease [J].
Winge, K ;
Skau, AM ;
Stimpel, H ;
Nielsen, KK ;
Werdelin, L .
NEUROUROLOGY AND URODYNAMICS, 2006, 25 (02) :116-122
[35]   Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease [J].
Winge, K ;
Friberg, L ;
Werdelin, L ;
Nielsen, KK ;
Stimpel, H .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) :842-850
[36]   Effects of dopaminergic treatment on bladder function in Parkinson's disease [J].
Winge, K ;
Werdelin, LM ;
Nielsen, KK ;
Stimpel, H .
NEUROUROLOGY AND URODYNAMICS, 2004, 23 (07) :689-696
[37]   Striatal dopamine level increases in the urinary storage phase in cats:: An in vivo microdialysis study [J].
Yamamoto, T ;
Sakakibara, R ;
Hashimoto, K ;
Nakazawa, K ;
Uchiyama, T ;
Liu, Z ;
Ito, T ;
Hattori, T .
NEUROSCIENCE, 2005, 135 (01) :299-303
[38]   THE DOPAMINE-D1 RECEPTOR AGONIST SKF-38393 SUPPRESSES DETRUSOR HYPERREFLEXIA IN THE MONKEY WITH PARKINSONISM INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) [J].
YOSHIMURA, N ;
MIZUTA, E ;
KUNO, S ;
SASA, M ;
YOSHIDA, O .
NEUROPHARMACOLOGY, 1993, 32 (04) :315-321
[39]   Patterns and stages of α-synucleinopathy -: Relevance in a population-based cohort [J].
Zaccai, J. ;
Brayne, C. ;
McKeith, I. ;
Matthews, F. ;
Ince, P. G. .
NEUROLOGY, 2008, 70 (13) :1042-1048